Hims & Hers sees lab testing as $1B business, WSJ reports

Hims & Hers (HIMS) Health is offering lab testing and sees the business as a $1B opportunity, Kelly Cloonan of Wall Street Journal reports. “You know, size of this market is, I think every single person in the country,” Hims Chief Executive Andrew Dudum told the Journal. He expects the offering to eventually represent a $1B business, Cloonan adds. Hims customers will access testing at Quest Diagnostics’ (DGX), then receive results and consult with providers on the platform for a personalized plan that could include prescriptions, supplements or nutrition guidance, Dudum said.